A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2004
12/16/2004	CA2531569A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stemcell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transformation introducing the gene
12/16/2004	CA2528157A1 Cell-containing preparations
12/16/2004	CA2527967A1 Biologically active oils
12/16/2004	CA2526789A1 Cells used as carriers for bacteria
12/16/2004	CA2525401A1 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
12/16/2004	CA2524910A1 Therapeutical composition containing dendritic cells and use thereof
12/15/2004	EP1486214A1 Botulinum toxins for treating muscle spasm
12/15/2004	EP1486212A1 Combination of a mutant herepes virus and irinotecan for the treatment of cancer
12/15/2004	EP1486211A1 Compositions for treating cancer using viruses
12/15/2004	EP1486182A2 A device for delivering a preselected molecule into the systemic circulation
12/15/2004	EP1485487A2 Cartilage regeneration using chondrocyte and tgf-beta
12/15/2004	EP1485464A2 Methods of inducing differentiation in ex vivo expanded stem cells
12/15/2004	EP1485463A2 Lactobacillus strains
12/15/2004	EP1485140A1 Polymer composite loaded with cells
12/15/2004	EP1485124A2 Method of inducing an enhanced immune response against hiv
12/15/2004	EP1485119A1 Enhancing the availability of minerals by using biologically active peptides
12/15/2004	EP1485111A1 Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
12/15/2004	EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
12/15/2004	EP1453954A4 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
12/15/2004	EP1404845B1 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences
12/15/2004	EP1383515B1 Activation of natural killer cells by adenosine a3 receptor agonists
12/15/2004	EP1221937B1 Hybrid matrices and hybrid matrix mixtures
12/15/2004	EP1212358B1 Synthetic papillomavirus genes optimized for expression in human cells
12/15/2004	EP1101494B1 Composition for stimulating the synthesis of the melanic pigment and procedure to obtain it
12/15/2004	EP1047415B1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
12/15/2004	EP1019488B1 Feed product
12/15/2004	EP1015025B1 T-cell vaccination for the treatment of multiple sclerosis
12/15/2004	CN2662927Y Prostate treating bag
12/15/2004	CN1555417A Paramyxovirus vector for gene transfer to the cardiovascular system
12/15/2004	CN1555415A Synthetic HCV envelope proteins and their use for vaccination
12/15/2004	CN1555227A Enteral formulations
12/15/2004	CN1554764A Recombinant mva virus, and the use thereof
12/15/2004	CN1554410A Worm nutritiou health oral liquid and its preparing method
12/15/2004	CN1554405A Powder preparation for treating burn and skin trauma
12/15/2004	CN1554363A Anti-hepatitis b placenta specific factor extract with specific immunological activity and its preparing process
12/15/2004	CN1554362A Compound slow-release Anfennamin micro pill and preparing method
12/15/2004	CN1554361A Nano calcium
12/15/2004	CN1554285A Method for producing oyster tablet by adding oyster shell superfine powder
12/15/2004	CN1180079C Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
12/15/2004	CN1179749C Method for preparing tumor specific transfer factors
12/15/2004	CN1179744C Ointment having pain-killing relieving itching, removing toxic substances and promoting granulation function
12/15/2004	CN1179739C Burn film-coating agent
12/15/2004	CN1179737C Chinese medicine for curing rheumatoid disease
12/15/2004	CN1179734C Chinese medicine capsule for treating diabetes
12/15/2004	CN1179731C Medicine for treating dental diseases
12/15/2004	CN1179730C Wound-treating external-use medicine
12/15/2004	CN1179727C Epiderm specificity transfer factor
12/15/2004	CN1179666C Prepn of health food with hair blackening function
12/14/2004	US6831157 Process for the purification of serum albumin
12/14/2004	US6831086 In presence of proteins which retain biological activity; synergistic with benzalkonium chloride; easily removed by adsorption on active carbon or dialysis
12/14/2004	US6830924 For anticarcinogenic drugs; kits
12/14/2004	US6830763 Continuous acidification demineralization process for producing osteoinductive bone; and osteoinductive bone produced thereby
12/14/2004	US6830750 Reduction of oxidative stress factors with Lactobacillus plantarum
12/14/2004	US6830749 Antitumor agents; gene therapy
12/14/2004	CA2104957C Redirection of cellular immunity by receptor chimeras
12/14/2004	CA1341468C Preparation of functional human factor viii
12/13/2004	CA2467768A1 Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like loxl for stimulating the formation of elastic fibres
12/09/2004	WO2004106500A1 Method for increasing the yield of proliferating primary keratinocytes
12/09/2004	WO2004106499A1 Method for expanding cells
12/09/2004	WO2004106372A1 Deer antler extract for promoting angiogenesis
12/09/2004	WO2004105912A2 Method of producing eggshell powder
12/09/2004	WO2004105837A2 Compounds and methods for improving platelet recovery and function
12/09/2004	WO2004105822A1 New product
12/09/2004	WO2004105787A1 Methods of using combinations of egf-2 and egf-20 to treat central nervous system disorders
12/09/2004	WO2004105701A2 Compositions and methods for symptomatic relief
12/09/2004	WO2004105504A2 Dietary supplements and methods of preparing and administering dietary supplements
12/09/2004	WO2004091505A3 Bacteriophage for lysis of methylobacterium and compositions and uses thereof
12/09/2004	WO2004085659A3 Mutant vesicular stomatitis viruses and uses thereof
12/09/2004	WO2004037851A3 Colostrinin and peptides thereof as modulators of intracellular signaling molecules and inhibitors of apoptosis
12/09/2004	WO2004026238A3 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers
12/09/2004	WO2004012503A3 Compositions comprising muscle progenitor cells and uses thereof
12/09/2004	WO2004005531A3 Targeting and tracking of cells to specific organs and tissues in vivo
12/09/2004	WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies
12/09/2004	US20040250305 Adoptive transfer and uses thereof
12/09/2004	US20040249143 Hagfish cathelin-associated antimicrobial peptides and genes
12/09/2004	US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248946 Beverage treated with nicotine
12/09/2004	US20040248871 Prevent cell differentiation
12/09/2004	US20040248845 Hyaluronic acid in soft gel form
12/09/2004	US20040248826 Treatment of cancer by in vivo gene-transfer induced TIMP-3 expression
12/09/2004	US20040248813 Compounds and methods for the modulation of cd154
12/09/2004	US20040248802 Poly-Glu, Tyr for neuroprotective therapy
12/09/2004	US20040248782 Long lasting glucagon-like peptide2(glp-2)for the treatment of gastrointestinal diseases and disorders
12/09/2004	US20040248771 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
12/09/2004	US20040248767 Modulating serum amyloid a interaction with tanis and agents useful for same
12/09/2004	US20040248722 Methods for forming hardened tubes and sheets
12/09/2004	US20040248296 HIV therapeutic
12/09/2004	US20040248292 Keratinocytes obtained from embryonic stem cells of mammals
12/09/2004	US20040248288 Compositions and methods for efficient aav vector production
12/09/2004	US20040248278 Streptococcus expressing lymphocytic protein for use in prevention and treatment of insulin resistance, obesity, autism and attention deficit/hyperactivity disorders
12/09/2004	US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/09/2004	US20040248083 Viral plasmid comprising heterologous or synthetic dimerisation sequences which promotes dimer formation of plasmid transcripts and prevents recombination between plasmid transcripts and another retrovirus present in genome; gene transfer tool; bioreactor
12/09/2004	US20040247694 Formulation for the treatment of obesity
12/09/2004	US20040247693 Modifying the fatty acid composition of cell membranes of organs and tissues
12/09/2004	US20040247691 wound healing and tissue forming compositions with suitable cells affixed to prosthetic devices; microbeads are prepared by coagulation and emulsification of fibrinogen, thrombin and factor XIII without gluteraldehyde as a crosslinking agent
12/09/2004	US20040247622 Methods and compounds for the treatment of immunologically-mediated diseases using Mycobacterium vaccae
12/09/2004	US20040247615 A nucleic acid comprising a nucleotide sequence encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region; adenovector or DNA plasmid vaccine; cultured cells expressing the nucleic acid; vaccination
12/09/2004	US20040247598 In particular of delayed-type hypersensitivity; especially administering an IL-18 binding protein or a derivative, an expression vector or a genetically engineered cell, optionally with an antiinflammatory agent such as a COX-inhibitor.

1 ... 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 ... 1259